/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Bristol Myers Squibb\n \n\n\n\n\n
Nov 21 1:21 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 20, 2009 6:50 PM EST
\n\n \n U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years) - Business Wire\n \n \n
\n\n Nov 19, 2009 8:30 AM EST
\n\n \n Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc. - Business Wire\n \n \n
\n\n Nov 17, 2009 11:55 AM EST
\n\n \n Model N and Sierra Atlantic Extend Software Development Partnership to Bring Leading Revenue Management Solutions to Indian Pharmaceutical Market - Marketwire Canada\n \n \n
\n\n Nov 17, 2009 11:33 AM EST
\n\n \n Model N and Sierra Atlantic Extend Software Development Partnership to Bring Leading Revenue Management Solutions to Indian Pharmaceutical Market - Marketwire\n \n \n
\n\n Nov 17, 2009 7:00 AM EST
\n\n \n Apollo Global Announces Executive Appointments - Business Wire\n \n \n
\n\n Nov 17, 2009 6:54 AM EST
\n\n \n RothmanResearch.com Complimentary Analysis on BBD, HON, EFX, KMB, SWY and BMY - Marketwire\n \n \n
\n\n Nov 16, 2009 3:00 PM EST
\n\n \n Movers and downers in the market for Monday the 16th - US Equity News\n \n \n
\n
\n\n");